Covering Bahrain, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya, Oman, Palestine, Qatar, Saudi Arabia, Sudan, Syria, UAE and Yemen
This seminar will provide you with an essential overview of the key areas of pharmaceutical regulatory affairs in the Middle East. This two-day course will focus on practical aspects and will cover the regulatory requirements and developments in the individual countries as well as discuss harmonisation in the region.
Benefits of attending:
- Centralised registration in the Gulf (GCC-DR)
- Middle East Regulatory Conference (MERC)
- MERC follow-up activities
- Industry regulatory groups and activities
This meeting runs back-to-back with our Medical Device Regulations in the Middle East and North Africa 19-20 June 2019, and there is a further £200/€280 discount when booked together.
To find out more call Customer Services on +44 (0)20 7749 4730 or e-mail info@management-forum.co.uk
This seminar will be of particular interest to:
Economic overview of the Middle East
The pharmaceutical regulatory environment in the Middle East – with individual presentations on:
Each regional presentation will cover:
Harmonisation and recent developments
Final discussion and objectives review
| 29-30 Jun 2020 | |||
| 29-30 Jun 2020 | Rembrandt Hotel, London | GBP 1,499.00 EUR 2,099.00 USD 2,338.00 + VAT @ 20.00% |
Enrol now |
“Speakers of a very high quality. EXCELLENT.”
Marianne Serritzlev, Senior Regulatory Affairs Specialist, PHARMANOVIA A/S
“Speakers are definitely experts in their area and have a depth of knowledge. Well worth it if you need an update on product registration issues / processes in the region.”
Zul Mamon, Senior Consultant, Responsible Person and Pharmacist, Pharma Experts Limited
“Overall good”
Ravi Shah, Senior RA Consultant, Atnahs
“Good introduction ”
Mark Pellett, Associate Director, Biogen Idec Ltd
“It is a valuable training ”
Rouba Rahi, Medical Pharmacovigilance & Regulatory Officer, Modern Quality Est.
“Really good course, gives a general overview of all countries ”
Carlota Coll, Regulatory Affairs Expert, GALENICUM HEALTH, S.L.
“Great speakers and happy to answer any questions. Very knowledgable. ”
Charlie Atherton, Regulatory Affairs Assistant, Gilead Sciences International
“Great speakers - it was possible to ask every question. Great country specific knowledge regarding the guidelines (all up-to-date). ”
Sabrina Waitz, International Drug Regulatory Affairs Manager, Octapharma Pharmazeutika Prod.Ges.m.b.H.
“It is so obvious that the speakers are highly experienced and have a huge knowledge regarding the region, but some of the presentations were a bit complicated to follow. Simply one of the best courses I have ever attended! ”
Nermin Ipek, Global Regulatory Affairs Manager, Ferring Pharmaceuticals Inc
“Good and interesting ”
Niina Lantelankallio, Regulatory Affairs Specialist, Santen Oy
“The course was very good and gave a comprehensive overview of the regulatory requirements within the Middle East region. This coupled with the experience and knowledge of the two presenters who were able to give their advice on specific enquiries..”
Shane Freeth, Regulatory Associate, RB
“Very interesting and helpful for my job”
Anne-Valerie Faucher, GALDERMA Recherche & Developpement
“Very good”
Marie Bailey, Regulatory Affairs Manager, Wockhardt (UK) Ltd
“It has been the best course I attended, focused on the topics, effective and clear. It will be very useful for the ongoing working activities. ”
Francesca Porchia, Regulatory Affairs Specialist , Abiogen Pharma S.p.A.
“Excellent, thorough and comprehensive.”
Emily-Jane Bowles, Regulatory Liaison, EEMEA, MSD Europe Inc.
“I liked it very much”
ROSA URZAY, TECHNICIAN, FAES FARMA, S.A.
“Very interesting seminar”
Audrey Yahiya, International Regulatory Affairs Pharmacist, Horus Pharma